- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Insulin glargine new formulation HOE901
Total 622 results
-
Buckinghamshire Healthcare NHS TrustNovo Nordisk A/SUnknownDiabetes Mellitus, Type 1United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1 | Healthy VolunteersGermany
-
Gan and Lee Pharmaceuticals, USACompletedDiabetes Mellitus, Type 1Germany
-
Eli Lilly and CompanyCompletedType 2 Diabetes | Chronic Kidney DiseaseMexico, United States, Hungary, Ukraine, Brazil, Spain, Romania, South Africa, Poland
-
SanofiCompletedDiabetes Mellitus, Type 1Belarus
-
SanofiCompletedInsulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal InsulinDiabetes Mellitus, Type 2United States
-
Novo Nordisk A/SCompleted
-
National Institute of Neurosciences and Hospital...Completed
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, India, Israel, Russian Federation, Slovakia, Canada, Serbia, United Kingdom, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Greece, India, Netherlands, Poland, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Russian Federation, Puerto Rico, United States, Australia, Hungary, Poland, Romania, Spain
-
SanofiCompletedDiabetes Mellitus, Type 2Argentina
-
GWT-TUD GmbHCompletedType 2 DiabetesGermany
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Israel, Russian Federation, United Kingdom, Taiwan, Argentina, Finland, Hungary, Macedonia, The Former Yugoslav Republic of, Malaysia, Mexico, Norway, Serbia, South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, South Africa, Canada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Slovakia, Canada, South Africa, Puerto Rico, Poland
-
Eli Lilly and CompanyCompletedType 1 Diabetes | Type 2 DiabetesUnited States
-
GeropharmCompletedClamp StudyRussian Federation
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Taiwan, South Africa, Korea, Republic of, Spain, Brazil, India, Peru, Philippines, United Kingdom, Hong Kong, France, Mexico
-
SanofiCompletedDiabetes Mellitus, Type 1France
-
prof dr Pieter GillardUniversity Hospital, Antwerp; Onze Lieve Vrouw HospitalCompleted
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2
-
US Department of Veterans AffairsCompletedHyperglycemia | DiabetesUnited States
-
Emory UniversitySanofiCompletedType 2 Diabetes | Inpatient HyperglycemiaUnited States
-
SanofiCompletedDiabetes Mellitus, Type 2Algeria, Brazil, Israel, Lebanon, Mexico, Morocco, Peru, Saudi Arabia, United Arab Emirates, Venezuela
-
PfizerCompletedDiabetes Mellitus, Type 2Germany, Netherlands, Sweden, Poland, Belgium, Finland, France, Norway, Spain, Switzerland
-
Mylan Inc.Mylan GmbHCompletedType 2 DiabetesUnited States, Jordan, Korea, Republic of, Slovakia, South Africa, Taiwan
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1 | Healthy VolunteersUnited States
-
SanofiCompletedDiabetes Mellitus, Type 2United States
-
Mylan Inc.Mylan GmbHCompletedType 1 Diabetes MellitusCzechia, United States, Canada, Estonia, Germany, Hungary, Latvia, Slovakia
-
Mylan Inc.Mylan GmbHCompletedType 1 DiabetesUnited States, Canada, Czechia, Estonia, Germany, Hungary, Latvia, Romania, Slovakia, South Africa, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Russian Federation, Serbia, Turkey, Algeria, Czechia
-
SanofiCompletedDiabetes Mellitus, Type 1Tunisia, South Africa, Algeria, Argentina, Brazil, Colombia, Kuwait, Mexico, Saudi Arabia
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusBrazil, Canada, Mexico, India, Australia, China, Korea, Republic of
-
India Diabetes Research Foundation & Dr. A. Ramachandran...Completed
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Healthy VolunteersGermany
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesGermany
-
SanofiCompletedType 2 DiabetesFrance
-
Skane University HospitalMedical Research Council; Skane County Council Research & Development FoundationCompletedType 2 Diabetes | Secondary Drug FailureSweden
-
University of AarhusNovo Nordisk A/S; The Danish Diabetes Association; The Institute of Experimental...Completed
-
Charles Drew University of Medicine and ScienceNational Center for Research Resources (NCRR)Completed
-
AstraZenecaEli Lilly and CompanyCompleted
-
SanofiCompletedType 2 Diabetes MellitusJapan
-
Boehringer IngelheimTerminated